Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Boni

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomesG Cocconi, B Di Blasio, C Boni, et al.
Hepatology (Baltimore, Md.)|April 3, 2001
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapyC Boni, A Penna, G S Ogg, et al.
The European Journal of Neuroscience|March 22, 2002
Altered regulation of the 5-HT system in the brain of MAO-A knock-out miceA Evrard, I Malagié, A-M Laporte, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2013
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancerG Bisagni, A Musolino, M Panebianco, et al.
British Journal of Cancer|November 26, 2009
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trialC Bengala, F Bertolini, N Malavasi, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine developmentV Lamonaca, G Missale, S Urbani, et al.
Gastroenterology|January 1, 1997
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infectionsA Bertoletti, M M D'Elios, C Boni, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|February 25, 2003
[Therapeutic efficacy of chloroquine in the uncomplicated malaria due to Plasmodium falciparum in hospital patients in central Ivory Coast (1997-2000)]K D Adou-Bryn, K Krelo, C F G Akoussi, et al.
Tumori|November 1, 1996
Neoadjuvant chemotherapy with continuous infusion of cisplatin and fluorouracil in stage II-IV, M0 squamous cell carcinoma of the head and neckC Boni, G Moretti, L Savoldi, et al.
International Journal of Cancer|August 5, 2000
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC)C Boni, G Bisagni, L Savoldi, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2005
Primary chemotherapy in operable breast carcinoma comparing CMF (cyclophosphamide, methotrexate, 5-fluorouracil) with an anthracycline-containing regimen: short-term responses translated into long-term outcomesG Cocconi, B Di Blasio, C Boni, et al.
Hepatology (Baltimore, Md.)|April 3, 2001
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapyC Boni, A Penna, G S Ogg, et al.
The European Journal of Neuroscience|March 22, 2002
Altered regulation of the 5-HT system in the brain of MAO-A knock-out miceA Evrard, I Malagié, A-M Laporte, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2013
The Breast Avastin Trial: phase II study of bevacizumab maintenance therapy after induction chemotherapy with docetaxel and capecitabine for the first-line treatment of patients with locally recurrent or metastatic breast cancerG Bisagni, A Musolino, M Panebianco, et al.
British Journal of Cancer|November 26, 2009
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trialC Bengala, F Bertolini, N Malavasi, et al.
Hepatology (Baltimore, Md.)|September 25, 1999
Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine developmentV Lamonaca, G Missale, S Urbani, et al.
Gastroenterology|January 1, 1997
Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infectionsA Bertoletti, M M D'Elios, C Boni, et al.
Bulletin De La Societe De Pathologie Exotique (1990)|February 25, 2003
[Therapeutic efficacy of chloroquine in the uncomplicated malaria due to Plasmodium falciparum in hospital patients in central Ivory Coast (1997-2000)]K D Adou-Bryn, K Krelo, C F G Akoussi, et al.
Tumori|November 1, 1996
Neoadjuvant chemotherapy with continuous infusion of cisplatin and fluorouracil in stage II-IV, M0 squamous cell carcinoma of the head and neckC Boni, G Moretti, L Savoldi, et al.
International Journal of Cancer|August 5, 2000
Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: a phase II study of the italian oncology group for clinical research (GOIRC)C Boni, G Bisagni, L Savoldi, et al.
Pageof 14